AAAAAA

   
Results: 1-9 |
Results: 9
The role of high density lipoprotein in sepsis
Authors: van Leeuwen, HJ van Beek, AP Dallinga-Thie, GM van Strijp, JAG Verhoef, J van Kessel, KPM
Citation: Hj. Van Leeuwen et al., The role of high density lipoprotein in sepsis, NETH J MED, 59(3), 2001, pp. 102-110
A novel flow cytometric assay to quantify soluble CD14 concentration in human serum
Authors: Antal-Szalmas, P Szollosi, I Lakos, G Kiss, E Csipo, I Sumegi, A Sipka, S van Strijp, JAG van Kessel, KPM Szegedi, G
Citation: P. Antal-szalmas et al., A novel flow cytometric assay to quantify soluble CD14 concentration in human serum, CYTOMETRY, 45(2), 2001, pp. 115-123
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification ofmembrane lipids with L-lysine
Authors: Peschel, A Jack, RW Otto, M Collins, LV Staubitz, P Nicholson, G Kalbacher, H Nieuwenhuizen, WF Jung, G Tarkowski, A van Kessel, KPM van Strijp, JAG
Citation: A. Peschel et al., Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification ofmembrane lipids with L-lysine, J EXP MED, 193(9), 2001, pp. 1067-1076
Diverging pathways for lipopolysaccharide and CD14 in human monocytes
Authors: Antal-Szalmas, P Poppelier, MJJG Broekhuizen, R Verhoef, J van Strijp, JAG van Kessel, KPM
Citation: P. Antal-szalmas et al., Diverging pathways for lipopolysaccharide and CD14 in human monocytes, CYTOMETRY, 41(4), 2000, pp. 279-288
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS
Authors: de Haas, CJC van Leeuwen, HJ Verhoef, J van Kessel, KPM van Strijp, JAG
Citation: Cjc. De Haas et al., Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS, J IMMUNOL M, 242(1-2), 2000, pp. 79-89
Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide
Authors: de Haas, CJC Poppelier, MJJG van Kessel, KPM van Strijp, JAG
Citation: Cjc. De Haas et al., Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide, INFEC IMMUN, 68(9), 2000, pp. 4954-4960
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation
Authors: de Haas, CJC van Leeuwen, EMM van Bommel, T Verhoef, J van Kessel, KPM van Strijp, JAG
Citation: Cjc. De Haas et al., Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation, INFEC IMMUN, 68(4), 2000, pp. 1753-1759
Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate
Authors: Veldkamp, KE Heezius, HCJM Verhoef, J van Strijp, JAG van Kessel, KPM
Citation: Ke. Veldkamp et al., Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate, INFEC IMMUN, 68(10), 2000, pp. 5908-5913
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS
Authors: de Haas, CJC Van der Zee, R Benaissa-Trouw, B van Kessel, KPM Verhoef, J van Strijp, JAG
Citation: Cjc. De Haas et al., Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS, INFEC IMMUN, 67(6), 1999, pp. 2790-2796
Risultati: 1-9 |